Antibody alone is not a stimulator of exocytosis of weibel-palade bodies from human endothelial cells

Transplantation

Volumn 94, Issue 8, 2012, Pages 794-801

  Meli, Athinoula ^a   Carter, Tom ^b   McCormack, Ann ^a   Hannah, Matthew J ^b   Rose, Marlene L ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Human leukocyte antigen; von Willebrand factor; Weibel Palade body

Indexed keywords

CALCIUM ION; COMPLEMENT; ENHANCED GREEN FLUORESCENT PROTEIN; HISTAMINE; HLA ANTIBODY; HLA ANTIGEN CLASS 1 ANTIBODY; HLA ANTIGEN CLASS 2 ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY L2; MONOCLONAL ANTIBODY L243; MONOCLONAL ANTIBODY W6 32; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AORTIC ENDOTHELIAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXOCYTOSIS; HEART MICROVASCULAR ENDOTHELIAL CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL; WEIBEL PALADE BODY;

ANIMALS; CALCIUM; ENDOTHELIAL CELLS; EXOCYTOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; ISOANTIBODIES; RABBITS; VON WILLEBRAND FACTOR; WEIBEL-PALADE BODIES;

EID: 84868214914     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182669129     Document Type: Article

References (30)

1. Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 2004; 4: 438.
2. Smith JD, Hamour IM, Banner NR, et al. C4d fixing, luminex binding antibodiesVa new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007; 7: 2809.
3. Smith JD, Banner NR, Hamour IM, et al. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant 2011; 11: 312.
4. Rose ML, Coles MI, Griffin RJ, et al. Expression of class I and class II major histocompatibility antigens in normal and transplanted human heart. Transplantation 1986; 41: 776.
5. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710.
6. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteriaVan addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
7. Murata K, Baldwin WM 3rd. Mechanisms of complement activation, c4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev (Orlando) 2009; 23: 139.
8. Smith RN, Colvin RB. Chronic alloantibody mediated rejection. Semin Immunol 2011; 24: 15.
9. Jin YP, Singh RP, Du ZY, et al. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol 2002; 168: 5415.
10. Zhang X, Rozengurt E, Reed EF. HLA class I molecules partner with integrin A4 to stimulate endothelial cell proliferation and migration. Sci Signal 2010; 3: ra85.
11. Jin YP, Fishbein MC, Said JW, et al. Anti-HLA class I antibodymediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol 2004; 65: 291.
12. Bian H, Reed EF. Anti-HLA class I antibodies transduce signals in endothelial cells resulting in FGF receptor translocation, down-regulation of ICAM-1 and cell proliferation. Transplant Proc 2001; 33: 311.
13. Yamakuchi M, Kirkiles-Smith NC, Ferlito M, et al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci USA 2007; 104: 1301.
14. Morrell CN, Murata K, Swaim AM, et al. In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ Res 2008; 102: 777.
15. Rondaij MG, Bierings R, Kragt A, et al. Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26: 1002.
16. Knipe L, Meli A, Hewlett L, et al. A revised model for the secretion of tPA and cytokines from cultured endothelial cells. Blood 2010; 116: 2183.
17. Kilgore KS, Schmid E, Shanley TP, et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa b activation. Am J Pathol 1997; 150: 2019.
18. Benzaquen LR, Nicholson-Weller A, Halperin JA. Terminal complement proteins C5b-9 release basic fibroblast growth factor and plateletderived growth factor from endothelial cells. J Exp Med 1994;179:985.
19. Suttorp N, Seeger W, Zinsky S, et al. Complement complex C5b-8 induces PGI2 formation in cultured endothelial cells. Am J Physiol 1987; 253: C13.
20. Hattori R, Hamilton KK, McEver RP, et al. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989; 264: 9053.
21. Tedesco F, Pausa M, Nardon E, et al. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 1997; 185: 1619.
22. Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995; 181: 21.
23. Erent M, Meli A, Moisoi N, et al. Rate, extent and concentration dependence of histamine-evoked Weibel-Palade body exocytosis determined from individual fusion events in human endothelial cells. J Physiol 2007; 583: 195.
24. Hannah MJ, Skehel P, Erent M, et al. Differential kinetics of cell surface loss of von Willebrand factor and its propolypeptide after secretion from Weibel-Palade bodies in living human endothelial cells. J Biol Chem 2005; 280: 22827.
25. Weibel ER, Palade GE. New cytoplasmic components in arterial endothelia. J Cell Biol 1964; 23: 101.
26. Birch KA, Ewenstein BM, Golan DE, et al. Prolonged peak elevations in cytoplasmic free calcium ions, derived from intracellular stores, correlate with the extent of thrombin-stimulated exocytosis in single human umbilical vein endothelial cells. J Cell Physiol 1994; 160: 545.
27. Frearson JA, Harrison P, Scrutton MC, et al. Differential regulation of von Willebrand factor exocytosis and prostacyclin synthesis in electropermeabilized endothelial cell monolayers. Biochem J 1995; 309(pt 2): 473.
28. Zupancic G, Ogden D, Magnus CJ, et al. Differential exocytosis from human endothelial cells evoked by high intracellular ca(2+) concentration. J Physiol 2002; 544: 741.
29. Holder AL, Wolf S, Walshe C, et al. Expression of endothelial intercellular adhesion molecule-1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum Immunol 2008; 69: 71.
30. McDouall RM, Batten P, McCormack A, et al.MHCclass II expression on human heart microvascular endothelial cells: exquisite sensitivity to interferon-F and natural killer cells. Transplantation 1997; 64: 1175.